Skip to main content
. 2017 Jun 6;19(10):1997–2004. doi: 10.1016/j.celrep.2017.05.035

Table 1.

Characteristics of Study Participants According to Extent of Hepatic Steatosis, n = 133

No Steatosis (n = 52) Mild Steatosis (n = 41) Severe Steatosis (n = 40) p
Female sex 27 (51) 14 (34) 18 (45) 0.229
Age (years) 49 ± 2 51 ± 2 49 ± 2 0.634
BMI (kg/m2) 39 ± 1 41 ± 1 41 ± 1 0.442
Body fat (%) 45 ± 1 45 ± 2 46 ± 1 0.695
Fasting glucose (mmol/L) 5.2 ± 0.1 5.2 ± 0.1 5.4 ± 0.1 0.301
Triglycerides (mmol/L) 1.3 ± 0.1 1.6 ± 0.1 1.7 ± 0.2a 0.039
Cholesterol (mmol/L) 4.9 ± 0.1 4.9 ± 0.2 5.0 ± 0.2 0.671
High-density lipoprotein (mmol/L) 1.2 ± 0.0 1.1 ± 0.1 1.1 ± 0.0 0.287
Low-density lipoprotein (mmol/L) 3.0 ± 0.1 3.1 ± 0.2 3.2 ± 0.1 0.620
Alanine aminotransferase (U/L) 26 ± 2 38 ± 3b 40 ± 3c <0.001
Aspartate aminotransferase (U/L) 22 ± 1 30 ± 3 32 ± 3b 0.004
Gamma-glutamyl transpeptidase (U/L) 34 ± 4 42 ± 7 42 ± 4 0.320
C-reactive protein (mg/L) 4.9 ± 0.9 6.0 ± 1.0 7.6 ± 1.3 0.197
Resting energy expenditure (kcal/day) 1,862 ± 48 2,000 ± 72 1,931 ± 54 0.256
IHTG (%) 2.9 ± 0.2 10.4 ± 0.4c 23.3 ± 1.0,c,d <0.001

Data are count (%) or mean ± SEM. No, mild, and severe steatosis were defined as intrahepatic triglycerides (IHTG) <5.56%, 5.56%–15%, or >15%, respectively.

a

p < 0.05 versus no steatosis.

b

p < 0.01 versus no steatosis.

c

p < 0.001 versus no steatosis.

d

p < 0.001 versus mild steatosis.